Montelukast Dicyclohexylamine salt is a known impurity (often referenced as EP Impurity G or DCHA salt) of the asthma drug Montelukast, characterized as a white powder, a salt formed between Montelukast acid and Dicyclohexylamine, used as a reference standard for method development, QC, and validation in pharmaceutical analysis, helping ensure the purity and safety of Montelukast drug products. Its structure combines the Montelukast molecule with Dicyclohexylamine, crucial for identifying and quantifying this specific impurity in API manufacturing.